Seroconversion rates following COVID-19 vaccination among patients with cancer.

MLA

Thakkar, Astha, et al. “Seroconversion Rates Following COVID-19 Vaccination among Patients with Cancer.” Cancer Cell, vol. 39, no. 8, Aug. 2021, p. 1081. EBSCOhost, https://doi.org/10.1016/j.ccell.2021.06.002.

APA

Thakkar, A., Gonzalez-Lugo, J. D., Goradia, N., Gali, R., Shapiro, L. C., Pradhan, K., Rahman, S., Kim, S. Y., Ko, B., Sica, R. A., Kornblum, N., Bachier-Rodriguez, L., McCort, M., Goel, S., Perez-Soler, R., Packer, S., Sparano, J., Gartrell, B., Makower, D., … Halmos, B. (2021). Seroconversion rates following COVID-19 vaccination among patients with cancer. Cancer Cell, 39(8), 1081. https://doi.org/10.1016/j.ccell.2021.06.002

Chicago

Thakkar, Astha, Jesus D Gonzalez-Lugo, Niyati Goradia, Radhika Gali, Lauren C Shapiro, Kith Pradhan, Shafia Rahman, et al. 2021. “Seroconversion Rates Following COVID-19 Vaccination among Patients with Cancer.” Cancer Cell 39 (8): 1081. doi:10.1016/j.ccell.2021.06.002.